Edition:
United Kingdom

Tom Hals

Judge's unorthodox approach has huge opioid settlement within reach

19 Oct 2019

From the start of the sprawling U.S. litigation seeking to hold drugmakers and distributors liable for the country's opioid epidemic, Judge Dan Polster has made one thing clear: he never wanted a trial.

OxyContin maker Purdue gets brief shield from litigation

12 Oct 2019

OxyContin maker Purdue Pharma LP won a court order on Friday briefly pausing the sprawling opioid litigation against the company so it can try to make headway on its proposed legal settlement that it says is worth $10 billion.

OxyContin maker Purdue begins showdown to halt opioid lawsuits

11 Oct 2019

OxyContin maker Purdue Pharma LP will ask a U.S. Bankruptcy Judge on Friday to pause litigation against the company and its owners over the objections of U.S. states that allege the company is trying to protect the controlling Sackler family.

OxyContin maker Purdue begins showdown to halt opioid lawsuits

11 Oct 2019

Oct 11 OxyContin maker Purdue Pharma LP will ask a U.S. Bankruptcy Judge on Friday to pause litigation against the company and its owners over the objections of U.S. states that allege the company is trying to protect the controlling Sackler family.

U.S. judge urges parties to wisely use Purdue opioid settlement funds

11 Oct 2019

A U.S. bankruptcy judge on Thursday urged parties that will benefit from a proposed settlement with OxyContin maker Purdue Pharma LP to focus on addressing the opioid addiction crisis and avoid battling over the deal's billions of dollars.

U.S. judge urges parties to wisely use Purdue opioid settlement funds

10 Oct 2019

Oct 10 A U.S. bankruptcy judge on Thursday urged parties that will benefit from a proposed settlement with OxyContin maker Purdue Pharma LP to focus on addressing the opioid addiction crisis and avoid battling over the deal's billions of dollars.

Massive jury award against J&J highlights risks of its legal strategy

09 Oct 2019

A jury award that hit Johnson & Johnson with $8 billion in punitive damages for a case involving its anti-psychotic drug Risperdal highlights the risks of the drugmaker's all-or-nothing legal strategy, several legal experts told Reuters on Wednesday. | Video

Cracks in Purdue's proposed opioid settlement as Arizona backs out

08 Oct 2019

The U.S. state of Arizona withdrew its support for a proposed nationwide opioid settlement with Purdue Pharma LP, saying the maker of OxyContin sought to "undermine material terms of the deal," according to a court filing on Monday.

Giuliani's unusual role key to exposing internal Trump documents

02 Oct 2019

Rudy Giuliani's wide-ranging work for U.S. President Donald Trump could make it tougher for him to claim Ukraine-related documents demanded by Congress as part of its impeachment inquiry are confidential and protected under lawyer-client privilege, experts said.

Abuse of power, not criminality, key to Trump impeachment

27 Sep 2019

Democratic lawmakers have a strong case for impeaching U.S. President Donald Trump if they can prove he abused his power when he asked Ukraine's president to "look into" an American political rival, several legal experts said.

World News